HealthEquity Reports Third Quarter Ended October 31, 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall as megacap tech drags; Iran developments watched
- Oil falls 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
HealthEquity (HQY) Tops Q3 EPS by 7c, Revenues Beat; Offers FY21 EPS/Revenue Outlook
December 7, 2020 4:04 PM ESTHealthEquity (NASDAQ: HQY) reported Q3 EPS of $0.43, $0.07 better than the analyst estimate of $0.36. Revenue for the quarter came in at $179.4 million versus the consensus estimate of $176.78 million.
Highlights of the third quarter include:
Revenue of $179.4 million, an increase of 14% compared to $157.1 million in Q3 FY20.Net income of $1.8 million, with non-GAAP net income of $32.2 million, compared to net loss of $21.3 million and non-GAAP net income of $30.3 million in Q3 FY20.Net income per diluted share of $0.02, with non-GAAP net income per diluted share of $0.41,... More